A double-blind evaluation of lysivane in the treatment of Parkinson's disease.
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009132:Muscles / Q000627:therapeutic use*; D010276:Parasympatholytics / Q000188:drug therapy*; D010300:Parkinson Disease / Q000627:therapeutic use*; D010919:Placebos
D010276:Parasympatholytics; D010919:Placebos